ARCHIVES

Clinical Trials: Phase I Trial of Karenitecin Begins, BioNumerik Says

This article is from The Cancer Letter archive.

Vol. 25 No. 09 | March 5, 1999

Download PDF Visit The Full Archive

Related Articles

In Brief: NCI Would Get Extra $115 Million Over Three Years Under Budget Amendment By Alabama Senator

June 4, 1982

Duke recruits Judd Moul as chief of urology.

July 9, 2004

FDA Advisors Discuses Establishment of Standards for Showing Equivalence

December 17, 1999

AACR’s First Special Conference Scheduled for Oct. 23-27 at Cape Cod

July 22, 1988

GAO Criticizes Eppley, NCI For ‘Deficiencies’ In Review, Monitoring, Management of Contract

February 24, 1978

NC-Approved Clinical Trials

June 27, 2003